Patents by Inventor Ronsar Eid

Ronsar Eid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cycloalkyl Piperidine Tachykinin Receptor Antagonists
    Publication number: 20080153851
    Abstract: The present invention is directed to certain piperidine compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.
    Type: Application
    Filed: November 18, 2005
    Publication date: June 26, 2008
    Inventors: Robert J. DeVita, Sander G. Mills, Ronsar Eid, Jonathan R. Young
  • Piperidinyl Piperidine Tachykinin Receptor Antagonists
    Publication number: 20080146588
    Abstract: The present invention is directed to certain piperidine compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.
    Type: Application
    Filed: November 18, 2005
    Publication date: June 19, 2008
    Inventors: Robert J. Devita, Sander G. Mills, Ronsar Eid, Jonathan R. Young
  • Cycloalkyl Keto Piperidine Tachykinin Receptor Antagonists
    Publication number: 20080076783
    Abstract: The present invention is directed to certain piperidine compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.
    Type: Application
    Filed: November 18, 2005
    Publication date: March 27, 2008
    Applicant: MERCK & CO., INC.
    Inventors: Robert DeVita, Sander Mills, Ronsar Eid, Jonathan Young